A Study to Test if TEV-50717 is Safe and Effective in Relieving Abnormal Involuntary Movements in Cerebral Palsy

Summary

Study TV50717-CNS-30081 is a 55-week study in which participants who have successfully completed the parent study (Study TV50717-CNS-30080) may be eligible to enroll in this study. The primary objective of this study is to evaluate the safety and tolerability of long-term therapy with TEV-50717 in children and adolescents with DCP. The secondary objective of this study is to evaluate the efficacy of long-term therapy with TEV-50717 in reducing the severity of DCP.

Timeline

Start

2020-02-04

Primary completion

2023-02-14

Completion

2023-02-14

Outcome

Outcome not reported

Stopped: “Failure of TV50717-CNS-30080 (parent study) to meet the primary efficacy endpoint”

Drugs

Indications